Home Other Building Blocks Benzenemethanamine, N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-, (αS)-

Benzenemethanamine, N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-, (αS)-

CAS No.:
119356-77-3
Catalog Number:
AG000INO
Molecular Formula:
C21H23NO
Molecular Weight:
305.4134
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG000INO
Chemical Name:
Benzenemethanamine, N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-, (αS)-
CAS Number:
119356-77-3
Molecular Formula:
C21H23NO
Molecular Weight:
305.4134
MDL Number:
MFCD00865355
IUPAC Name:
(1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine
InChI:
InChI=1S/C21H23NO/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21/h3-14,20H,15-16H2,1-2H3/t20-/m0/s1
InChI Key:
USRHYDPUVLEVMC-FQEVSTJZSA-N
SMILES:
CN([C@H](c1ccccc1)CCOc1cccc2c1cccc2)C
UNII:
GB2433A4M3
Properties
Complexity:
337  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
305.178g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
305.421g/mol
Monoisotopic Mass:
305.178g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
12.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.1  
Literature
Title Journal
Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins. Toxicology and applied pharmacology 20161115
Effect of dapoxetine on ejaculatory performance and related brain neuronal activity in rapid ejaculator rats. The journal of sexual medicine 20121001
Dapoxetine: a new option in the medical management of premature ejaculation. Therapeutic advances in urology 20121001
Evolving therapeutic strategies for premature ejaculation: The search for on-demand treatment - topical versus systemic. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20121001
A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation. International journal of andrology 20120801
Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells. Naunyn-Schmiedeberg's archives of pharmacology 20120701
Pharmacology for the treatment of premature ejaculation. Pharmacological reviews 20120701
Block of cloned Kv4.3 potassium channels by dapoxetine. Neuropharmacology 20120601
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation. Drug safety 20120501
Chiral recognition of dapoxetine enantiomers with methylated-gamma-cyclodextrin: a validated capillary electrophoresis method. Journal of pharmaceutical and biomedical analysis 20120325
On-demand tramadol hydrochloride use in premature ejaculation treatment. Urology 20120101
Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation. Core evidence 20120101
Patient reporting encouraged during monitoring of dapoxetine in New Zealand. Drug safety 20111101
Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. The journal of sexual medicine 20111001
An overview of pharmacotherapy in premature ejaculation. The journal of sexual medicine 20111001
Medical therapy for premature ejaculation. Therapeutic advances in urology 20111001
Therapeutic targets for premature ejaculation. Maturitas 20110901
Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs in R&D 20110301
Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. The journal of sexual medicine 20110201
Dapoxetine for premature ejaculation. Clinical pharmacology and therapeutics 20110101
Update on treatments for premature ejaculation. International journal of clinical practice 20110101
Quality of online pharmacies and websites selling prescription drugs: a systematic review. Journal of medical Internet research 20110101
Pharmacokinetics of dapoxetine hydrochloride in healthy Chinese, Japanese, and Caucasian men. Journal of clinical pharmacology 20101201
[Dapoxetine in treatment of premature ejaculation: a systematic review]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20100818
Counterfeit dapoxetine sold on the Internet contains undisclosed sildenafil. International journal of clinical practice 20100801
Dapoxetine: in premature ejaculation. Drugs 20100730
Dapoxetine for premature ejaculation. Expert opinion on pharmacotherapy 20100701
Available and future therapies for premature ejaculation. Drugs of today (Barcelona, Spain : 1998) 20100701
Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation. The journal of sexual medicine 20100601
Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. The journal of sexual medicine 20100601
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European urology 20100501
Organic vs. psychogenic? The Manichean diagnosis in sexual medicine. The journal of sexual medicine 20100501
The dapoxetine paradox. BJU international 20100401
[Therapy for male patients with sexual dysfunction]. Therapeutische Umschau. Revue therapeutique 20100301
Premature ejaculation: treatment update. International journal of STD & AIDS 20100201
Dapoxetine. Premature ejaculation: not worth the risk. Prescrire international 20100201
Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. The journal of sexual medicine 20100101
Highly efficient, enantioselective syntheses of (S)-(+)- and (R)-(-)-dapoxetine starting with 3-phenyl-1-propanol. The Journal of organic chemistry 20100101
Recent advances in the treatment of premature ejaculation. Drug design, development and therapy 20100101
Challenges in the pharmacotherapy of urogenital disorders. Frontiers in pharmacology 20100101
Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement. Journal of pharmaceutical and biomedical analysis 20091205
Dapoxetine: a novel treatment for premature ejaculation. Drugs of today (Barcelona, Spain : 1998) 20090901
Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation. Current opinion in investigational drugs (London, England : 2000) 20090701
Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects. Journal of clinical pharmacology 20090601
[Premature ejaculation]. Der Urologe. Ausg. A 20090601
Dapoxetine debate and conflict of interest. The journal of sexual medicine 20090501
Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. European urology 20090401
Editorial comment on: Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. European urology 20090401
Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU international 20090301
[Efficacy and safety of selective serotonin re-uptake inhibitors in the treatment of premature ejaculation: a systematic evaluation]. Zhonghua nan ke xue = National journal of andrology 20090301
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice. BJU international 20090201
MMIX: annus festine lente? BJU international 20090101
Emerging treatments for premature ejaculation: focus on dapoxetine. Neuropsychiatric disease and treatment 20090101
Effect of dapoxetine on the pharmacokinetics and hemodynamic effects of tamsulosin in men on a stable dose of tamsulosin. Journal of clinical pharmacology 20081201
Rational use of dapoxetine for the treatment of premature ejaculation. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081001
The pharmacological treatment of premature ejaculation. BJU international 20080901
Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. BJU international 20080901
Re: François Giuliano, Donald L. Patrick, Hartmut Porst, et Al. for the 3004 study group. Premature ejaculation: results from a five-country European observational study. Eur urol 2008;53:1048-57. European urology 20080601
Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080501
Regarding Waldinger and Schweitzer's 'premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case'. The journal of sexual medicine 20080401
Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. The journal of sexual medicine 20080401
Interview with Dr François Giuliano (by Christine McKillop). New avenues in the pharmacological treatment of premature ejaculation. European urology 20071001
W is for Wilbert's wee willy (which tends to go off prematurely). CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20070925
The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men. The journal of sexual medicine 20070701
Selective serotonin reuptake inhibitors in the treatment of premature ejaculation. Chinese medical journal 20070605
Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation. Therapeutics and clinical risk management 20070601
Identifying and treating premature ejaculation: importance of the sexual history. Cleveland Clinic journal of medicine 20070501
[Update of pharmacotherapy for premature ejaculation]. Zhonghua nan ke xue = National journal of andrology 20070501
Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine. European urology 20070301
Dapoxetine has no pharmacokinetic or cognitive interactions with ethanol in healthy male volunteers. Journal of clinical pharmacology 20070301
Development of in situ ion selective sensors for dissolution. Analytica chimica acta 20070102
Effect of acute dapoxetine administration on the pudendal motoneuron reflex in anesthetized rats: comparison with paroxetine. The Journal of urology 20070101
Dapoxetine in the treatment of premature ejaculation. Clinical neuropharmacology 20070101
Dapoxetine and paroxetine for the treatment of premature ejaculation. Clinical neuropharmacology 20070101
Premature ejaculation. Indian journal of urology : IJU : journal of the Urological Society of India 20070101
New agents in the treatment of premature ejaculation. Neuropsychiatric disease and treatment 20061201
Dapoxetine treatment of premature ejaculation. Lancet (London, England) 20061125
Dapoxetine for treatment of premature ejaculation. Lancet (London, England) 20061111
Treatment of premature ejaculation: new drugs and treatment strategies. Current urology reports 20061101
Medical therapy for premature ejaculation. Lancet (London, England) 20060909
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (London, England) 20060909
Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: Impact of age and effects of a high-fat meal. Journal of clinical pharmacology 20060901
Pharmacologic treatment of rapid ejaculation: levels of evidence-based review. Current clinical pharmacology 20060901
Just hold on a minute (or should it be two?). BJU international 20060701
What's the point? BJU international 20060301
Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. Journal of clinical pharmacology 20060301
Emerging drugs for premature ejaculation. Expert opinion on emerging drugs 20060301
Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU international 20060201
Late-stage clinical development in lower urogenital targets: sexual dysfunction. British journal of pharmacology 20060201
Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. International journal of impotence research 20060101
Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Clinical neuropharmacology 20060101
The era of ESSTIs is slowly approaching? BJU international 20050701
Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment. World journal of urology 20050601
Dapoxetine: LY 210448. Drugs in R&D 20050101
Mind over matter: CNS-based approaches to urological diseases. BJU international 20041201
The brain leads the way. BJU international 20041101
Properties